Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables and no. of employees. Unidades: specified in variables Fewer than 250 employees 250 or more employees Total No. of companies carrying out R&D in Biotechnology 1.006 73 1.079 %Companies according to biotechnology used: Genetic code 34 55 35 %Companies according to biotechnology used: Functional units 44 53 44 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 25 47 26 %Companies according to biotechnology used: Bioprocesses 48 64 49 %Companies according to biotechnology used: Sub-cellular organisms 8 15 8 %Companies according to biotechnology used: Bio-computing 23 23 23 %Companies according to biotechnology used: Nanobiotechnology 15 12 15 %Companies according to biotechnology used: Other 12 11 12 Companies in which biotechnology activities are: Main and/or exclusive 503 16 519 Companies in which biotechnology activities are: A secondary line of business 158 21 179 Companies in which biotechnology activities are: A tool necessary for production 345 36 381 %Company by field(s) of ultimate application of biotechnology use: Human Health 47 51 48 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 22 4 21 %Company by field(s) of ultimate application of biotechnology use: Food products 33 34 33 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 22 21 22 %Company by field(s) of ultimate application of biotechnology use: Environment 17 21 17 %Company by field(s) of ultimate application of biotechnology use: Industry 15 8 15 Personnel in R&D in biotechnology (no. of persons) 7.556 2.239 9.795 Personnel in R&D in biotechnology (no. of persons): Researchers 4.379 1.194 5.573 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 3.177 1.045 4.222 Personnel in R&D in biotechnology (no. of persons): women 4.032 1.267 5.298 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.279 646 2.925 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 1.752 621 2.373 Personnel in R&D in biotechnology (FTE) 5.209,9 1.618,7 6.828,6 Personnel in R&D in biotechnology (FTE): Researchers 3.191,6 914,9 4.106,5 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.018,3 703,8 2.722,1 Personnel in R&D in biotechnology (FTE): women 2.872,2 939,6 3.811,7 Personnel in R&D in biotechnology (FTE): (women) Researchers 1.682,6 508,1 2.190,7 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.189,5 431,5 1.621 Internal expenditure on R&D (thousands of euros) 402.391 131.434 533.826 1) By nature of the expense: Current expenses 365.997 126.959 492.955 1.1) Remuneration to researchers 153.274 50.166 203.439 1.2) Remuneration to technicians and assistants 67.291 29.559 96.850 1.3) Other current expenses 145.432 47.234 192.666 2) By nature of the expense: Capital expenses 36.395 4.476 40.870 2.1) Land and buildings 6.634 888 7.521 2.2) Equipment and instruments 28.690 3.388 32.078 2.3) Acquisition of specific R&D software 1.071 200 1.270 1) By origin of the funds: National funds 329.975 102.895 432.869 1.1) Own funds 239.006 80.039 319.046 1.2) From companies 30.715 8.538 39.253 1.3) Public Administration funds 57.667 12.396 70.063 1.4) From Universities 156 0 156 1.5) From non profit private institutions 2.431 1.921 4.351 1) By origin of the funds: Foreign funds 72.416 28.540 100.956 2.1) From EU programmes 18.073 1.998 20.070 2.2) Other foreign funds 54.344 26.542 80.886 Purchase of R&D services in biotechnology (thousands of euros) 76.625 62.000 138.625 Purchase of R&D services in biotechnology (thousands of euros): In Spain 64.575 36.539 101.114 Purchase of R&D services in biotechnology (thousands of euros): Abroad 12.050 25.462 37.512 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 48 25 46 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 10 13 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 12 12 12 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 17 14 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 19 18 19 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 20 12 19 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 18 21 18 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 36 37 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 50 44 49 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 20 11 19 % Companies that have requested biotechnology patents in Biotechnology 15 22 15 Number of patents requested 397 69 466 % Companies with income of an international origin related to biotechnological activities 25,3 20,5 24,9 % Turnover representing income of an international origin related to biotechnological activities 4 0,7 0,9 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 49,5 81 71,3 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 50,5 19,1 28,7 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 76,2 99,2 92,2 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 7,8 . 2,4 % Income of an international origin related with activities according to the classification: Operating source abroad 3,2 0,4 1,3 % Income of an international origin related with activities according to the classification: Other 12,7 0,4 4,2 Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute